National Planning Corporation’s Integra LifeSciences IART Stock Holding History

National Planning Corporation’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-203	Closed	-$4.51K	–	1296
2014 Q4	$4.51K	Buy	+203	New	+$4.12K	﹤0.01%	2365

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

National Planning Corporation's IART Position: Q1 2015 in Review

National Planning Corporation sold out of Integra LifeSciences (IART) in Q1 2015, closing a stake of 203 shares — an estimated $4.51K sold.

National Planning Corporation first reported a position in IART in Q4 2014 and held it in 1 quarter. The position peaked at $4.51K in Q4 2014. 168 funds tracked by Wall St. Rank hold IART as of Q1 2015.

National Planning Corporation reported no remaining Integra LifeSciences position as of Q1 2015 after selling out during the quarter.
National Planning Corporation sold 203 Integra LifeSciences shares in Q1 2015, an estimated $4.51K.
National Planning Corporation first reported a position in Integra LifeSciences in Q4 2014 and held it in 1 quarter.
National Planning Corporation's Integra LifeSciences position peaked at $4.51K in Q4 2014.
168 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2015.

Based on National Planning Corporation's 13F filing for Q1 2015, filed 12 May 2015.